(ARQT) |
| 0 (0%) 09-18 01:00 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 31.76 |
| Resistance 1: | 27.19 |
| Pivot price: | 24.24 |
| Support 1: | 24.66 |
| Support 2: | 23.10 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.220 |
| Book Value | 1.760 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.364 |
| Profit Margin (%) | 6.15 |
| Operating Margin (%) | 12.65 |
| Return on Assets (ttm) | 5.1 |
| Return on Equity (ttm) | 15.9 |
Company news
Thu, 17 Sep 2026
Arcutis Biotherapeutics (ARQT) Moves 11.2% Higher: Will This Strength Last? - Yahoo Finance
Wed, 16 Sep 2026
Former Arcutis (NASDAQ: ARQT) officer plans multimillion-dollar stock sale - Stock Titan
Wed, 16 Sep 2026
ARQT: ZORYVE's growth, pipeline expansion, and digital initiatives drive robust outlook and cash flow - TradingView
Wed, 16 Sep 2026
ARQT: Strong ZORYVE sales, pipeline expansion, and AI-driven initiatives fuel sustained growth - TradingView
Tue, 15 Sep 2026
Arcutis Biotherapeutics (NASDAQ: ARQT) director plans $114K stock sale - Stock Titan
Mon, 14 Sep 2026
The Technical Signals Behind (ARQT) That Institutions Follow - Stock Traders Daily
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
